Submitted by Anonymous (not verified) on 15 September 2026 - 15:30
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 8, Status: Authorised